Garrett Gray - Feb 1, 2023 Form 4 Insider Report for Checkpoint Therapeutics, Inc. (CKPT)

Role
Chief Financial Officer
Signature
/s/ Garrett Gray
Stock symbol
CKPT
Transactions as of
Feb 1, 2023
Transactions value $
-$15,108
Form type
4
Date filed
2/3/2023, 07:00 PM
Previous filing
Jan 12, 2023
Next filing
Mar 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CKPT Common Stock Sale -$15.1K -3.15K -6% $4.79 49.4K Feb 1, 2023 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 In connection with the vesting of 5,675 shares, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Gray's tax withholding obligations. Mr. Gray had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
F2 Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $4.75 to $4.84. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Includes shares of restricted common stock, which vest over various time periods.